Sucessful use of thalidomide in severe gastrointestinal Behçet's disease

Yu Kai Lim,J. Keating,R. Steele
DOI: https://doi.org/10.1111/ans.12978
IF: 1.7
2015-06-01
ANZ Journal of Surgery
Abstract:Behçet’s disease is rare in the European population. A 44-year-old woman presented to our department with iron deficiency anaemia and was found to have a large solitary ulcer in the rectum (Fig. 1) with no diagnostic features on histopathology. This was removed with an anterior resection but recurrent symptomatic ulceration in the proximal colon required repeat resections and ultimately an ileostomy. The non-specific features of the intestinal pathology, the presence of oral, skin and corneal ulceration and a weak positive pathergy test was consistent with Behçet’s disease. Multiple ileal ulcers proximal to the stoma resulted in further resections for bleeding and anaemia requiring multiple admissions for red cell transfusion. Sequential trials of treatment with corticosteroids, azathioprine, infliximab, mycophenolate mofetil, interferon alpha 2a and cyclosporine proved ineffective in preventing recurrent ileal ulceration and bleeding. After seven operations and six medical therapies, thalidomide was started at 100 mg/day. A week after introducing thalidomide, her mouth ulcers healed and no transfusion or surgery has been required in the subsequent 3 years. Treatment recommendations for Behçet’s disease are based on expert opinion, small trials and case series. Recommended first-line treatment is with corticosteroids for induction and thiopurines to reduce relapse. If this fails, the use of tumour necrosis factor-α inhibitors are considered. Thalidomide is usually considered the last-line therapy for gastrointestinal Behçet’s but its use is well documented but not widely known by the surgical community. The immunomodulatory effects of thalidomide are due to a reduction in levels of tumour necrosis factor-α because of degradation of its encoding mRNA. The efficacy of thalidomide has been reported in both juvenile and adult practice. The well-recognized teratogenic effects of thalidomide must always be borne in mind; however, it appears to be a valuable drug in this challenging condition.
What problem does this paper attempt to address?